These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4013351)

  • 1. [Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure].
    Mauersberger H; Rangoonwala B; Ehrlich E
    Wien Med Wochenschr; 1985 Apr; 135(8):205-13. PubMed ID: 4013351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
    Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y
    Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin.
    Viherkoski M; Huikko M; Varjoranta K
    Ann Clin Res; 1981 Feb; 13(1):11-5. PubMed ID: 7018361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
    Allman S; Norris RJ
    J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical amd metabolic results of a particular combination thiazide-antialdosterone in heart failure].
    Miraglia G; Nava A; Dalla Volta S
    Clin Ter; 1974 Mar; 68(5):445-51. PubMed ID: 4599565
    [No Abstract]   [Full Text] [Related]  

  • 7. Spironolactone in the management of congestive cardiac failure: a review.
    Muller J
    Clin Ther; 1986; 9(1):63-76. PubMed ID: 2880664
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension].
    Bachour G
    Med Klin Prax; 1982 May; 77(10):54-8. PubMed ID: 6808328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of diuretic therapy.
    Rowe WS
    Med J Aust; 1975 Mar; 1(12):392-4. PubMed ID: 1143129
    [No Abstract]   [Full Text] [Related]  

  • 12. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):480-5. PubMed ID: 3714756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of diuretics in congestive heart failure.
    Hall WD
    Med Times; 1979 Jan; 107(1):24-32. PubMed ID: 763082
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
    Levy B
    J Clin Pharmacol; 1977 Jul; 17(7):420-30. PubMed ID: 328540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basis and clinical aspects of diuretic drug therapy].
    Marone C; Beretta-Piccoli C; Weidmann P
    Ther Umsch; 1979 Jul; 36(7):660-7. PubMed ID: 473110
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.